Mahama says Ghana is one of five African countries using mRNA in vaccine research
President John Dramani Mahama says new research labs will help Ghana develop vaccines and reduce its reliance on foreign supplies.
President John Dramani Mahama says Ghana is one of only five African countries using messenger RNA, or mRNA, to research and develop vaccines. He made the remarks while commissioning new laboratories at the Noguchi Memorial Institute for Medical Research.
The new facilities include laboratories for mRNA and protein research. They are expected to give Ghanaian scientists more space and equipment to test ideas and work with international partners. Mahama said the labs would support research into both existing and emerging infectious diseases.
Mahama pointed to the COVID-19 pandemic as a reason for Ghana to invest in vaccine development. He said disruptions to global supply chains exposed the risks of relying on foreign manufacturers, as Western countries met their own demand before making doses available to others. He said the investment was intended to reduce Ghana’s dependence on outside supplies, particularly during public health emergencies.
The National Vaccine Institute described the new mRNA laboratory as an important step toward Ghana’s goal of developing new vaccines. The technology was used in some COVID-19 vaccines and works by giving cells instructions to make a specific protein.
Mahama also praised the institute’s efforts to build international partnerships, saying those ties would help connect Ghanaian researchers with the wider scientific community.
Comments